154 results on '"Eisen DB"'
Search Results
2. Ustekinumab, another biologic with potential to help patients with hidradenitis suppurativa?
- Author
-
Eisen, DB
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Biological Products ,Hidradenitis Suppurativa ,Humans ,Severity of Illness Index ,Ustekinumab ,Oncology and Carcinogenesis ,Dermatology & Venereal Diseases ,Clinical sciences - Published
- 2016
3. Hidradenitis suppurativa: a review with a focus on treatment data.
- Author
-
Barlev, D, Eisen, DB, and Alikhan, A
- Subjects
Humans ,Hidradenitis Suppurativa ,Retinoids ,Tetracyclines ,Androgen Antagonists ,Tumor Necrosis Factor-alpha ,Immunosuppressive Agents ,Laser Therapy - Abstract
Hidradenitis suppurativa (HS) is a chronic disease of the follicular unit that often leads to marked impairment of quality of life and usually affects the axillary, perineum and inframammary regions resulting in tender subcutaneous nodules, abscesses, fibrosis and sinus tract formation. New updates on HS underscores the role of various genes as well as the innate and adaptive immune response in its pathogenesis. Although every patient requires an individualized approach to treatment, topical therapy and antibiotics are mainly used for mild to moderate disease, whereas various systemic immune modulators and/or surgical approaches play a pivotal role in moderate to severe disease. New treatments using various immune modulators, laser modalities and other novel agents provide clinicians with better ways of managing HS.
- Published
- 2015
4. Set-back versus buried vertical mattress suturing: Results of a randomized blinded trial
- Author
-
Wang, AS, Kleinerman, R, Armstrong, AW, Fitzmaurice, S, Pascucci, A, Awasthi, S, Ratnarathorn, M, Sivamani, R, King, TH, and Eisen, DB
- Subjects
buried vertical mattress suture ,cutaneous surgery ,scar evaluation ,set-back suture ,subcuticular closure technique ,wound eversion ,Clinical Research ,Dermatology & Venereal Diseases ,Clinical Sciences - Abstract
Background: The set-back suture, an absorbable dermal suturing technique, purportedly improves wound eversion and cosmetic outcomes. Objective: We sought to conduct a split-wound, prospective, randomized study to compare the cosmetic outcome and wound eversion achieved with the set-back suture and the buried vertical mattress suture (BVMS). Methods: A total of 46 surgical elliptical wounds were randomized to subcuticular closure with the set-back suture on half and the BVMS on the other. Maximum eversion height and width were measured immediately postoperatively. At 3 months, 2 blinded observers evaluated each scar using a 7-point Likert physician global scar assessment scale. Subjects and observers also completed the validated Patient and Observer Scar Assessment Scale, where a score of 6 represents normal-appearing skin and 60 represents worst imaginable scar. Results: In all, 42 subjects completed the study. The set-back suture provided statistically significant wound eversion. On the Likert scale, observers rated the set-back suture side 1 point better than the BVMS side. Both patient and observer total Patient and Observer Scar Assessment Scale scores were significantly lower for the set-back suture side (subject mean 13.0 ± 8.7 vs 16.2 ± 12.0 [P = .039]; observer mean 24.5 ± 10.4 vs 27.7 ± 13.6 [P = .028], respectively). Limitations: Single institution experience and relatively short follow-up are limitations. Conclusion: The set-back suture provides superior wound eversion and better cosmetic outcomes than the BVMS. © 2014 American Academy of Dermatology, Inc.
- Published
- 2014
5. Electrobrasion vs. manual dermabrasion: a randomized, double‐blind, comparative effectiveness trial
- Author
-
Kleinerman, R, Armstrong, AW, Ibrahimi, OA, King, TH, and Eisen, DB
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Comparative Effectiveness Research ,Clinical Research ,Patient Safety ,Clinical Trials and Supportive Activities ,6.3 Medical devices ,Evaluation of treatments and therapeutic interventions ,Cicatrix ,Dermabrasion ,Double-Blind Method ,Electrosurgery ,Female ,Humans ,Male ,Middle Aged ,Postoperative Complications ,Treatment Outcome ,Oncology and Carcinogenesis ,Dermatology & Venereal Diseases ,Clinical sciences - Abstract
BackgroundElectrobrasion, like dermabrasion, is a method of surgical planing that is purported to improve postoperative scarring. Data regarding its benefits and harms relative to dermabrasion are absent.ObjectiveTo compare the efficacy and potential harms of electrobrasion and dermabrasion.MethodsThis was a pragmatic, randomized, double-blind, split-scar intervention in patients with suboptimal surgical outcomes. Half of the wound was randomized to treatment with dermabrasion and half to electrobrasion. At 3-month follow-up, both the patient and a blinded investigator evaluated the wound.ResultsElectrobrasion and dermabrasion reduced the mean scores of the Manchester Scar Scale 1·6 and 1·3 points from baseline, respectively (P = 0·0003). The difference between treatments was not significant (P = 0·08). Global cosmetic improvement by physician and patient assessment indicated clinical improvement for both procedures but did not demonstrate statistical significance between treatments (P = 0·57, P = 0·32 for physician and patient, respectively).ConclusionsBoth dermabrasion and electrobrasion improved scars, but there was no significant difference between the outcomes of the two procedures on several measures. Procedure time and bleeding time were significantly lower for electrobrasion.
- Published
- 2014
6. Cosmetic Outcomes With The Use of 5-0 Polypropylene Versus 5-0 Fast Absorbing Plain Gut During Cutaneous Wound Closure: A Randomized Evaluator Blind Split Wound Trial
- Author
-
Eisen, DB, Zhuang, AR, Hasan, A, Sharon, VR, Bang, H, and Crispin, MK
- Subjects
Male ,Wound Healing ,Sutures ,Dermatologic Surgical Procedures ,Suture Techniques ,Polypropylenes ,Article ,Cicatrix ,Postoperative Complications ,Absorbable Implants ,Animals ,Humans ,Female ,Aged ,Skin - Abstract
BACKGROUND: Surgeons have mixed opinions regarding cosmetic outcomes of 5-0 fast absorbing plain (FG) gut relative to nonabsorbable suture material, such as 5-0 polypropylene (PP). High quality randomized trials comparing these two suture materials are lacking. OBJECTIVES: To determine whether the use of PP during layered repair of linear cutaneous surgery wounds improves scar cosmesis compared to wound closure with FG. METHODS: A randomized, split wound, comparative effectiveness trial was undertaken. Patients were evaluated 3 months after the intervention by two blinded physicians using the validated patient observer scar assessment scale (POSAS). Patient assessments were also captured using the same instrument as well as scar width and complications. RESULTS: The mean sum of the six components of the POSAS was 10.26 vs 12.74 for PP and FG, respectively, significantly (p
- Published
- 2019
7. Guidelines of care for the management of basal cell carcinoma
- Author
-
Baum, C, Bordeaux, JS, Brown, M, Busam, KJ, and Eisen, DB
- Abstract
© 2017 American Academy of Dermatology, Inc. Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed.
- Published
- 2018
8. Microneedle-assisted incubation during aminolaevulinic acid photodynamic therapy of actinic keratoses: a randomized controlled evaluator-blind trial
- Author
-
Lev-Tov, H, Larsen, L, Zackria, R, Chahal, H, Eisen, DB, and Sivamani, RK
- Subjects
Male ,Photosensitizing Agents ,Actinic ,integumentary system ,Dermatology & Venereal Diseases ,Clinical Sciences ,Oncology and Carcinogenesis ,Pain ,Aminolevulinic Acid ,Equipment Design ,Keratosis ,Middle Aged ,Photochemotherapy ,Needles ,80 and over ,Humans ,Single-Blind Method ,Female ,Forehead ,Prospective Studies ,Facial Dermatoses ,Pain Measurement ,Aged - Abstract
Photodynamic therapy (PDT) is a common method of treating actinic keratoses (AKs) that compares favorably to other treatment methods.(1,2) However, treatment is limited by prolonged incubation times required for the medication to penetrate the stratum corneum.(3) Microneedles (MNs) are micrometer scale needles that are capable of puncturing the stratum corneum with minimal pain.(4,5) They have been utilized for various applications, including enhanced drug delivery.6 Few studies have evaluated MNs in conjunction with PDT for AKs.(7) We sought to assess the utility of short solid MN arrays that penetrate to the epidermis in shortening the incubation time for aminolevulinic acid (ALA) in PDT for AKs. This article is protected by copyright. All rights reserved.
- Published
- 2017
9. Clarifying scar revision techniques and their proper use: In reply
- Author
-
Petukhova, TA, Ratnarathorn, M, and Eisen, DB
- Published
- 2016
10. Medical professional liability claims for Mohs micrographic surgery from 1989 to 2011
- Author
-
D'Souza, LS, Jalian, HR, Jalian, C, Alam, M, Eisen, DB, Avram, MM, and Ibrahimi, OA
- Subjects
humanities - Abstract
IMPORTANCE: Few studies specifically address lawsuits involving Mohs surgery. OBJECTIVE: To better characterize the types of medical professional liability claims involving Mohs surgery. DESIGN, SETTING, AND PARTICIPANTS: Retrospective legal document review of an online national database. Any legal proceeding involving the search words Mohs and cancer was included. MAINOUTCOMESAND MEASURES: Number of medical professional liability claims involving Mohs surgery for factors including year of litigation, location, physician specialty, injury sustained, cause of legal action, and verdict. RESULTS: Forty-two cases were identified, which occurred from 1989 to 2011. Of the cases identified, 26 involved non-Mohs surgeons as the primary defendant, mostly due to a delay of or failure in diagnosis (n = 16), cosmetic outcome issues (n = 8), lack of informed consent (n = 7), and a delay of or failure in referral to a Mohs surgeon (n = 6). Common causes for litigation against Mohs surgeons as the primary defendant (n = 16) were lack of proper informed consent (n = 5) and cosmetic outcome issues (n = 4). Only 1 case against a Mohs surgeon was judged for the plaintiff. CONCLUSIONS AND RELEVANCE: The most common lawsuits pertaining to Mohs surgery list non-Mohs surgeonsasthe primary defendants. Closer coordination between non-Mohs surgeons and Mohs surgeons may help minimize risk to both parties and lead to better patient care. Small sample size is the primary limitation, in part owing to exclusion of out-of-court settlements from the database.
- Published
- 2015
11. In reply
- Author
-
Joo, J and Eisen, DB
- Published
- 2015
12. Who do you prefer? A study of public preferences for health care provider type in performing cutaneous surgery and cosmetic procedures in the United States
- Author
-
Bangash, HK, Ibrahimi, OA, Green, LJ, Alam, M, Eisen, DB, and Armstrong, AW
- Subjects
Adult ,Male ,Skin Neoplasms ,Adolescent ,Health Personnel ,Dermatology & Venereal Diseases ,Dermatologic Surgical Procedures ,Clinical Sciences ,Patient Preference ,Cosmetic Techniques ,Plastic ,Middle Aged ,United States ,Physician Assistants ,Patient Satisfaction ,Health Care Surveys ,Physicians ,Humans ,Surgery ,Female ,Clinical Competence ,Primary Care ,Aged - Abstract
BACKGROUND: The public preference for provider type in performing cutaneous surgery and cosmetic procedures is unknown in the United States. METHODS: An internet-based survey was administered to the lay public. Respondents were asked to select the health care provider (dermatologist, plastic surgeon, primary care physician, general surgeon, and nurse practitioner/physician's assistant) they mostly prefer to perform different cutaneous cosmetic and surgical procedures. RESULTS: Three hundred fifty-four respondents undertook the survey. Dermatologists were identified as the most preferable health care provider to evaluate and biopsy worrisome lesions on the face (69.8%), perform skin cancer surgery on the back (73.4%), perform skin cancer surgery on the face (62.7%), and perform laser procedures (56.3%) by most of the respondents. For filler injections, the responders similarly identified plastic surgeons and dermatologists (47.3% vs 44.6%, respectively) as the most preferred health care provider. For botulinum toxin injections, there was a slight preference for plastic surgeons followed by dermatologists (50.6% vs 38.4%). Plastic surgeons were the preferred health care provider for procedures such as liposuction (74.4%) and face-lift surgery (96.1%) by most of the respondents. CONCLUSION: Dermatologists are recognized as the preferred health care providers over plastic surgeons, primary care physicians, general surgeons, and nurse practitioners/physician's assistants to perform a variety of cutaneous cosmetic and surgical procedures including skin cancer surgery, on the face and body, and laser procedures. The general public expressed similar preferences for dermatologists and plastic surgeons regarding filler injections. © 2014 by the American Society for Dermatologic Surgery, Inc.
- Published
- 2014
13. Surgical complications: Disclosing adverse events and medical errors.
- Author
-
Wang AS and Eisen DB
- Published
- 2013
- Full Text
- View/download PDF
14. Clinical Significance Unveiled: Understanding the Meaning of FACE-Q Skin Cancer Scores for Improved Patient Care.
- Author
-
Veldhuizen IJ, Dusza SW, Kuo A, Aleisa A, Blue E, Adhikari S, Nadir U, Le K, Kazemi S, Sutton AV, Nijhawan RI, Eisen DB, Rossi AM, Srivastava D, Wysong A, Nehal KS, Klassen AF, and Lee EH
- Subjects
- Humans, Male, Female, Prospective Studies, Middle Aged, Aged, Cicatrix psychology, Patient Satisfaction, Adult, Aged, 80 and over, Surveys and Questionnaires, United States, Facial Neoplasms surgery, Facial Neoplasms psychology, Quality of Life psychology, Clinical Relevance, Skin Neoplasms psychology, Skin Neoplasms surgery, Mohs Surgery psychology, Patient Reported Outcome Measures
- Abstract
Objective: The FACE-Q Skin Cancer Module is a Patient-Reported Outcome Measure (PROM) utilized to assess outcomes following facial skin cancer resection. However, the lack of Minimal Important Difference (MID) estimates hinders the interpretability of the PROM scores. This study established MID estimates for the four outcome scales from the FACE-Q Skin Cancer Module using distribution-based methods., Methods: A prospective cohort study at four hospitals in the United States, enrolled participants who underwent Mohs Micrographic Surgery (MMS) for facial skin cancer between April 2020 and April 2022. Participants completed the Satisfaction with Facial Appearance, Appearance-related Psychosocial Distress, Cancer Worry, and Appraisal of Scars scales at four time points: pre-operatively, 2-week, 6-month, and 1-year post-surgery., Results: A total of 990 patients participated in the study, with completion rates of 98.4% for the pre-operative assessment, 70.8% at 2 weeks, 59.3% at 6 months, and 60.4% at 1 year. MID estimates, calculated using 0.2 standard deviation and 0.2 standardized response mean, were determined for the four scales. The mean MID estimates, based on a Rasch transformed score ranging from 0 to 100, were 5 for the Appraisal of Scars scale and 4 for the remaining three scales., Conclusion: This multicenter study provides valuable MID estimates for the FACE-Q Skin Cancer Module, specifically for the MMS patient population, enabling clinicians and researchers to better interpret scores, determine appropriate sample sizes, and apply the findings in clinical care., (© 2024 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
15. Aesthetic outcome of running subcuticular suture versus running horizontal mattress suture in closure of linear wounds of the trunk and extremities: A randomized evaluator-blinded split-wound comparative effectiveness trial.
- Author
-
Kwapnoski Z, Doost MS, Vy M, Danesh M, and Eisen DB
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Aged, Single-Blind Method, Extremities surgery, Extremities injuries, Treatment Outcome, Suture Techniques, Cicatrix prevention & control, Cicatrix etiology, Esthetics, Torso
- Abstract
Background: Both running horizontal mattress (HM) and running subcuticular (SQ) suturing techniques have been suggested to be superior to other running cuticular suturing techniques. These 2 techniques have not been directly compared., Objective: To compare cosmetic outcomes between a running HM and a running SQ technique in a split scar model following linear closure of trunk and extremity defects., Methods: Fifty patients were enrolled in a randomized, evaluator-blinded, split-scar study. One side of the surgical wound was randomized to receive one intervention (HM vs SQ) with the other side receiving the alternate intervention. The primary outcome was the Patient and Observer Scar Assessment Scale (POSAS) score at a minimum of 3 months postoperatively., Results: Observer POSAS sum of components was 19.49 and 17.76 for HM and SQ, respectively (P = .14). The mean score for patient overall opinion was 4.71 for HM and 3.50 for the SQ technique (P = .02). Overall opinion scores of evaluators were 3.87 and 3.29 for HM and SQ, respectively (P = .03)., Limitations: Single-center study of a relatively homogenous population., Conclusion: Although there was no significant difference in the sum of POSAS components between HM and SQ (P = .14), both patients and evaluators had a superior overall opinion of the SQ-treated side (patient P = .02, evaluator P = .03)., Competing Interests: Conflicts of interest None disclosed., (Copyright © 2024 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
16. Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study.
- Author
-
Curtis KK, Fakult NJ, Strunck JL, Aasi SZ, Ahn CS, Alam M, Bar AA, Behshad R, Bichakjian CK, Bolotin D, Boone SL, Bordeaux JS, Brewer JD, Carr DR, Carucci JA, Castillo JR, Christensen SR, Clark MA, Collins LK, Demer AM, Eisen DB, Feng H, Firoz BF, Grekin RC, Hirshburg JM, Holmes TE, Huang CC, Jennings TA, Jiang SIB, Konda S, Leitenberger JJ, Lewin JM, Maher IA, Ng E, Orengo IF, Samie FH, Saylor DK, Sharon VR, Soleymani T, Swetter SM, Tate JA, Van Beek MJ, Vidal NY, Vij A, Wysong A, Xu YG, Carroll BT, and Yu WY
- Subjects
- Humans, Clinical Trials as Topic standards, Mohs Surgery standards, Mohs Surgery methods, Melanoma surgery, Melanoma pathology, Delphi Technique, Consensus, Skin Neoplasms surgery, Skin Neoplasms pathology
- Abstract
Background: Mohs micrographic surgery (MMS) is a promising treatment modality for melanoma in situ (MIS). However, variations in surgical technique limit the generalizability of existing data and may impede future study of MMS in clinical trials., Methods: A modified Delphi method was selected to establish consensus on optimal MMS techniques for treating MIS in future clinical trials. The Delphi method was selected due to the limited current data, the wide range of techniques used in the field, and the intention to establish a standardized technique for future clinical trials. A literature review and interviews with experienced MMS surgeons were performed to identify dimensions of the MMS technique for MIS that (1) likely impacted costs or outcomes of the procedure, and (2) showed significant variability between surgeons. A total of 8 dimensions of technical variation were selected. The Delphi process consisted of 2 rounds of voting and commentary, during which 44 expert Mohs surgeons across the United States rated their agreement with specific recommendations using a Likert scale., Results: Five of eight recommendations achieved consensus in Round 1. All 3 of the remaining recommendations achieved consensus in Round 2. Techniques achieving consensus in Round 1 included the use of a starting peripheral margin of ≤5 mm, application of immunohistochemistry, frozen tissue processing, and resecting to the depth of subcutaneous fat. Consensus on the use of Wood's lamp, dermatoscope, and negative tissue controls was established in Round 2., Conclusions: This study generated 8 consensus recommendations intended to offer guidance for Mohs surgeons treating MIS. The adoption of these recommendations will promote standardization to facilitate comparisons of aggregate data in multicenter clinical trials.
- Published
- 2024
- Full Text
- View/download PDF
17. Pilomatrix Carcinoma: A Retrospective Chart Review of 17 Patients.
- Author
-
Amin M, Kneiber D, Cassarino D, and Eisen DB
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Aged, 80 and over, Retrospective Studies, Neoplasm Metastasis, Biopsy, Treatment Outcome, Pilomatrixoma pathology, Pilomatrixoma surgery, Skin Neoplasms pathology, Skin Neoplasms surgery, Hair Diseases pathology, Hair Diseases surgery
- Published
- 2024
- Full Text
- View/download PDF
18. Searching for biomarkers to help distinguish Merkel cell carcinoma from cutaneous small cell lung cancer with gene expression analysis.
- Author
-
Bloomstein JD, Doost MS, Meyer SN, Kiuru M, and Eisen DB
- Subjects
- Humans, Diagnosis, Differential, Gene Expression Profiling, Carcinoma, Merkel Cell genetics, Carcinoma, Merkel Cell pathology, Carcinoma, Merkel Cell metabolism, Skin Neoplasms genetics, Skin Neoplasms pathology, Lung Neoplasms genetics, Biomarkers, Tumor genetics, Small Cell Lung Carcinoma genetics
- Published
- 2024
- Full Text
- View/download PDF
19. Antibiotic adherence in dermatologic surgery: a Multicenter prospective cohort study.
- Author
-
Veerabagu SA, Aizman L, Cheng B, Lee MP, Barbieri JS, Golda N, Carrington AE, Mitevski AW, Bittar P, Carr DR, Eisen DB, Somani AK, Miller CJ, Sobanko JF, Shin TM, Higgins Ii HW, Giordano CN, and Etzkorn JR
- Subjects
- Humans, Prospective Studies, Female, Middle Aged, Male, Aged, Dermatologic Surgical Procedures adverse effects, Surgical Wound Infection prevention & control, Surgical Wound Infection epidemiology, Adult, United States, Surveys and Questionnaires statistics & numerical data, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents administration & dosage, Medication Adherence statistics & numerical data
- Abstract
Understanding patient non-adherence to prescribed antibiotics can inform clinical practices, patient counseling, and antibiotic efficacy study design in dermatology. The primary objective was to determine the rate of and reasons for antibiotic non-adherence in the dermatologic surgery setting. The secondary objective was to test the applicability of previously studied survey questions for antibiotic non-adherence screening in the dermatologic surgery setting. Five academic outpatient dermatologic surgery centers across the United States conducted one multicenter prospective cohort study. Dermatologic surgery patients ≥ 18 years of age who were prescribed an antibiotic were included as part of this study. 15.2% (42/276) of patients did not adhere to their antibiotic regimen after dermatologic surgery. Most common reasons for incomplete antibiotic courses included forgotten antibiotics (42.9%,18/42) and side effects (28.6%, 12/42). Previously evaluated questions to identify and predict non-adherence had modest performance in the dermatologic surgery setting (Area under the curve of 0.669 [95% CI (0.583-0.754)]). Antibiotic non-adherence after skin surgery is prevalent and commonly due to reasons that physicians can address with patients., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
20. Comparing Cosmetic Outcomes of Straight-Line Versus W-Plasty Techniques for Linear Postauricular Wound Closure: A Randomized Evaluator Blind Split-Scar Trial.
- Author
-
Mehrzad M, Kang AS, Armstrong AW, and Eisen DB
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Wound Closure Techniques, Esthetics, Treatment Outcome, Suture Techniques, Single-Blind Method, Aged, Cicatrix etiology
- Abstract
Background: Surgeons' opinions vary on the cosmetic outcome of straight-line (SL) versus broken-line (W-plasty) closure methods. To date, no studies have compared the 2 techniques in the split-scar design model that resolves the confounding individual patient factors that affects the scar outcome., Objective: Compare outcomes and wound cosmesis with SL versus W-plasty closure techniques., Methods: This clinical trial was conducted with 50 linear surgical wounds randomized to SL closure on half and W-plasty on the other half. At 3 months, patients and 2 masked observers evaluated each scar using the Patient and Observer Scar Assessment Scale (Patient Observer Scar Assessment Scale [POSAS])., Results: The mean (SD) sum of the POSAS observer component scores were 16.6 (6.18) for the SL side and 15.5 (6.37) for the W-plasty side ( p = .49). The mean (SD) sum of the POSAS patient scores were 14.4 (6.8) in SL and 15.1 (8.2) in W-plasty ( p = .59). The mean (SD) complications were 0.08 (0.06) for SL and 0.02 (0.14) for W-plasty ( p = .18)., Conclusion: No statistically significant difference in wound cosmesis or complications was noted between SL versus W-plasty closure techniques. Surgeons may want to consider whether the extra time involved in placing zigzag W-plasty lines is worthwhile., (Copyright © 2024 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. Aesthetic outcome of intermediate closure versus intermediate closure followed by 2-octyl cyanoacrylate: A randomized evaluator-blinded split-wound comparative effectiveness trial.
- Author
-
Kwapnoski Z, Doost MS, Vy M, and Eisen DB
- Subjects
- Humans, Cyanoacrylates therapeutic use, Sutures, Esthetics, Treatment Outcome, Cicatrix etiology, Cicatrix prevention & control, Cicatrix pathology, Suture Techniques
- Abstract
Background: Dermatologic surgeons are increasingly using surgical adhesives in their practice. Studies comparing sutured wounds to those that utilize a combination of suturing and skin adhesive have not been previously conducted., Objective: To compare the cosmetic outcome and patient wound care satisfaction of an intermediate suture closure with an intermediate suture closure followed by the application of 2-octyl cyanoacrylate (2-OCA)., Methods: Fifty patients were enrolled in a randomized, evaluator-blinded, split-scar study. Following intermediate sutured closure of a surgical defect, one side of the wound was randomized to receive an additional application of 2-OCA. After 3 months, the scar was assessed using the POSAS tool and patients reported wound care preferences., Results: As the primary outcome measure, the mean sum of observer POSAS was 12.80 for sutured closure alone versus 12.40 for sutured closures followed by 2-OCA (P = .49)., Limitations: Single-center study of a relatively homogenous population., Conclusion: Although there were no significant differences in scar cosmesis, both patients and observers tended to prefer the side with an additional application of 2-OCA in most POSAS components, in overall opinion, and in patient wound care satisfaction. Dermatologic surgeons may add this to their practice without sacrificing scar outcomes or patient satisfaction., Competing Interests: Conflicts of interest None disclosed., (Copyright © 2023 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
22. How We Do It: Application of Surgical Adhesive to Aid in Hemostasis During the Use of Interpolation Flaps.
- Author
-
Kwapnoski Z, Saffari Doost M, Vy M, and Eisen DB
- Subjects
- Humans, Hemostasis
- Published
- 2024
- Full Text
- View/download PDF
23. Performing research and publishing in the peer-reviewed medical literature should be a requirement for completion of post-graduate residency and fellowship training.
- Author
-
Alam M, Dirr MA, Anvery N, Christensen RE, Arndt KA, Brodell RT, Carr DR, Cartee TV, Dover JS, Eisen DB, Goldberg LH, Lawrence N, Lee M, Maher IA, Nehal KS, Sobanko JF, Walocko F, and Xu YG
- Subjects
- Humans, United States, Fellowships and Scholarships, Education, Medical, Graduate methods, Publishing, Internship and Residency
- Abstract
Graduate medical education (GME) in the USA is an increasingly organized and formalized process overseen by regulatory bodies, notably the American Council of Graduate Medical Education (ACGME), and associated specialty-specific Residency Review Committees (RRCs) to ensure that trainees, including residents and fellows, receive comprehensive, high-quality didactic education, clinical training, and research experience. Among the required elements of GME, performance of independent research is emphasized less than clinical and didactic education. In general, there are no ACGME requirements that trainees successfully publish papers in the peer reviewed. Indeed, unlike as is the case with procedure case logs, there are no minimum thresholds for specific numbers of abstracts presented, posters accepted, or manuscripts published. As such, while residencies and fellowships in certain disciplines or institutions may require considerable, documented research activity, others may not. Since future attending physicians are expected to be experts in their fields, able to digest relevant medical knowledge, critically evaluate emerging findings in the literature, and lead multi-professional healthcare teams, they must have a level of facility with the medical literature than can only be acquired by having performed research and having published papers themselves. Publishing one paper during training is easily attainable for all trainees. Having this be an ACGME requirement will necessitate protected time, research methods education, and mentorship for trainees. This can be accomplished without disrupting the other elements of resident and fellow training. From an ACGME perspective, required scholarly activity will support the competencies of practice-based learning and improvement as well as professionalism. In lay terms, benefits will be a higher level of education and attainment for trainees, and a potentially higher standard of health care for our patients., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
24. Mohs micrographic surgery versus wide local excision for the treatment of atypical fibroxanthoma: A retrospective cohort analysis.
- Author
-
Meyer SN, Ren Y, Taylor S, Kiuru M, and Eisen DB
- Abstract
Competing Interests: None disclosed.
- Published
- 2023
- Full Text
- View/download PDF
25. Update of penetrance estimates in Birt-Hogg-Dubé syndrome.
- Author
-
Bruinsma FJ, Dowty JG, Win AK, Goddard LC, Agrawal P, Attina' D, Bissada N, De Luise M, Eisen DB, Furuya M, Gasparre G, Genuardi M, Gerdes AM, Hansen TVO, Houweling AC, Johannesma PC, Lencastre A, Lim D, Lindor NM, Luzzi V, Lynch M, Maffé A, Menko FH, Michels G, Pulido JS, Ryu JH, Sattler EC, Steinlein OK, Tomassetti S, Tucker K, Turchetti D, van de Beek I, van Riel L, van Steensel M, Zenone T, Zompatori M, Walsh J, Bondavalli D, Maher ER, and Winship IM
- Subjects
- Humans, Male, Female, Aged, Penetrance, Proto-Oncogene Proteins genetics, Tumor Suppressor Proteins genetics, Birt-Hogg-Dube Syndrome genetics, Birt-Hogg-Dube Syndrome pathology, Colonic Polyps, Kidney Neoplasms epidemiology, Kidney Neoplasms genetics, Carcinoma, Renal Cell epidemiology, Carcinoma, Renal Cell genetics
- Abstract
Background: Birt-Hogg-Dubé (BHD) syndrome is a rare genetic syndrome caused by pathogenic or likely pathogenic germline variants in the FLCN gene. Patients with BHD syndrome have an increased risk of fibrofolliculomas, pulmonary cysts, pneumothorax and renal cell carcinoma. There is debate regarding whether colonic polyps should be added to the criteria. Previous risk estimates have mostly been based on small clinical case series., Methods: A comprehensive review was conducted to identify studies that had recruited families carrying pathogenic or likely pathogenic variants in FLCN . Pedigree data were requested from these studies and pooled. Segregation analysis was used to estimate the cumulative risk of each manifestation for carriers of FLCN pathogenic variants., Results: Our final dataset contained 204 families that were informative for at least one manifestation of BHD (67 families informative for skin manifestations, 63 for lung, 88 for renal carcinoma and 29 for polyps). By age 70 years, male carriers of the FLCN variant have an estimated 19% (95% CI 12% to 31%) risk of renal tumours, 87% (95% CI 80% to 92%) of lung involvement and 87% (95% CI 78% to 93%) of skin lesions, while female carriers had an estimated 21% (95% CI 13% to 32%) risk of renal tumours, 82% (95% CI 73% to 88%) of lung involvement and 78% (95% CI 67% to 85%) of skin lesions. The cumulative risk of colonic polyps by age 70 years old was 21% (95% CI 8% to 45%) for male carriers and 32% (95% CI 16% to 53%) for female carriers., Conclusions: These updated penetrance estimates, based on a large number of families, are important for the genetic counselling and clinical management of BHD syndrome., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
26. Response to "Comment on 'Guidelines of care for the management of actinic keratosis'".
- Author
-
Eisen DB, Schlesinger TE, and Frazer-Green L
- Subjects
- Humans, Keratosis, Actinic diagnosis, Keratosis, Actinic therapy, Skin Neoplasms prevention & control
- Abstract
Competing Interests: Conflicts of interest Dr Schlesinger serves as an investigator for AbbVie, Aclaris Therapeutics, Inc, Arcutis Premier Research, Arcutis Biotherapeutics, Akros, Allergan, Astellas Pharma US, AOBiome Therapeutics, Bioderma, Biofrontera, BioPharmx, Boehringer Ingelheim, Bristol-Myers Squibb, Cara Therapeutics, Castle BioScience, Celgene, Centocor Ortho Biotech, Inc, ChemoCentryx, Coherus Biosciences, Corrona, Inc, Demira, Dermavant Sciences, DT Pharmacy & DT Collagen, Eli Lilly and Company, Galderma USA, Genentech, Janssen Pharmaceuticals, Kinex, Kiniksa Pharmaceuticals, Ltd, LEO Pharmaceuticals, Merz Aesthetics, Novartis, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sebacia, Inc, Sienna Biopharmaceuticals, SiSaf Ltd, Tetra Derm Group, LLC, and Trevi receiving grants and/or research funding; as a consultant for AbbVie, Aclaris Therapeutics, Inc, Allergan, Inc, Almirall, BioFrontera, Bristol-Meyers Squibb, Castle Biosciences, Eli Lilly and Company, Evolus, Foundation for Research and Education in Dermatology, EPI Health, Galderma USA, LEO Pharmaceuticals, Lilly, MED Learning Group CME Program, Merz Aesthetics, MJH Associates, Nextphase, Novartis, Ortho Dermatologics, Pfizer, Inc, Prolacta Bioscience, Regeneron, SiSaf Ltd, Sun Pharma, Suneva Medical, UCB, Unilever, and Verrica receiving honoraria and/or fees; as a speaker for Aclaris, Almirall, Demira, DUSA, EPI Health, Regeneron, Sanofi Genzyme, Sun Pharma, Suneva Medical, Inc, and Sun Pharmaceutical Industries Ltd receiving honoraria; as an advisory board member for Allergan, Almirall, Amgen, Bioderma, Biofrontera AG, Celgene, Greenway Therapeutix (no compensation received), Remedly, Inc, and Suneva Medical, Inc receiving honoraria and/or stock; and as an independent contractor for SiSaf Ltd receiving grants and/or research funding. Drs Eisen and Green have no conflicts of interest to disclose.
- Published
- 2023
- Full Text
- View/download PDF
27. Merkel cell carcinoma treatment with Mohs micrographic surgery versus wide local excision: A retrospective cohort survival analysis.
- Author
-
Bloomstein JD and Eisen DB
- Subjects
- Humans, Mohs Surgery, Neoplasm Recurrence, Local pathology, Retrospective Studies, Survival Analysis, Carcinoma, Merkel Cell, Skin Neoplasms pathology
- Abstract
Competing Interests: Conflicts of interest None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
28. Undermining during cutaneous wound closure for wounds less than 3 cm in diameter: a randomized split wound comparative effectiveness trial.
- Author
-
Joo J, Pourang A, Tchanque-Fossuo CN, Armstrong AW, Tartar DM, King TH, Sivamani RK, and Eisen DB
- Subjects
- Aged, Dermatologic Surgical Procedures adverse effects, Female, Humans, Male, Skin pathology, Suture Techniques adverse effects, Treatment Outcome, Wound Healing, Cicatrix etiology, Soft Tissue Injuries complications
- Abstract
Undermining is thought to improve wound outcomes; however, randomized controlled data regarding its efficacy are lacking in humans. The objective of this randomized clinical trial was to determine whether undermining low to moderate tension wounds improves scar cosmesis compared to wound closure without undermining. Fifty-four patients, 18 years or older, undergoing primary linear closure of a cutaneous defect with predicted postoperative closure length of ≥ 3 cm on any anatomic site were screened. Four patients were excluded, 50 patients were enrolled, and 48 patients were seen in follow-up. Wounds were divided in half and one side was randomized to receive either no undermining or 2 cm of undermining. The other side received the unselected intervention. Three months, patients and 2 masked observers evaluated each scar using the Patient and Observer Scar Assessment Scale (POSAS). A total of 50 patients [mean (SD) age, 67.6 (11.5) years; 31 (64.6%) male; 48 (100%) white] were enrolled in the study. The mean (SD) sum of the POSAS observer component scores was 12.0 (6.05) for the undermined side and 11.1 (4.68) for the non-undermined side (P = .60). No statistically significant difference was found in the mean (SD) sum of the patient component for the POSAS score between the undermined side [15.9 (9.07)] and the non-undermined side [13.33 (6.20)] at 3 months. For wounds under low to moderate perceived tension, no statistically significant differences in scar outcome or total complications were noted between undermined wound halves and non-undermined halves.Trail Registry: Clinical trials.gov Identifier NCT02289859. https://clinicaltrials.gov/ct2/show/NCT02289859 ., (© 2021. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
29. Interrupted subcuticular suture spacing during linear wound closures and the effect on wound cosmesis: a randomized evaluator-blinded split-wound comparative effectiveness trial.
- Author
-
Eshagh K, Sklar LR, Pourang A, Armstrong AW, Dhaliwal H, and Eisen DB
- Subjects
- Humans, Suture Techniques adverse effects, Sutures adverse effects, Treatment Outcome, Wound Healing, Cicatrix etiology, Cicatrix pathology, Cicatrix prevention & control, Cosmetics
- Abstract
Background: Surgical reconstructions following Mohs micrographic surgery and standard surgical excisions are often closed with two layers of sutures: a deep subcuticular layer and a superficial cuticular layer. Some surgeons feel the need to place many deep sutures in order to reduce tension on cuticular sutures, as they believe this may decrease incidence of track marks and dehiscence, and lead to better cosmetic outcomes. However, others feel that a higher number of subcuticular sutures increases the risk of a suture reaction, which leads to patient anxiety and poorer wound cosmesis. To our knowledge, there are no studies published on the effect of subcuticular suture spacing on wound cosmesis., Objectives: To determine whether suturing with 1-cm interval subcuticular sutures results in better cosmetic outcomes than suturing with 2-cm interval subcuticular sutures., Methods: Fifty patients were enrolled in a randomized clinical trial using a split-wound model, where half of the wound was repaired with sutures spaced 2 cm apart and the other half was repaired with sutures spaced 1 cm apart (ClinicalTrials.gov identifier NCT03327922). Both the evaluators and patients were blinded as to which side received which treatment. The scar was evaluated 3 months post-surgery by two blinded observers and the patients themselves using the Patient and Observer Scar Assessment Scale (POSAS), a validated scar assessment instrument., Results: The total mean POSAS score for observers for the sides that received 1-cm interval subcuticular sutures and the sides that received 2-cm interval subcuticular sutures did not differ significantly at 3 months (P = 0·34). There was also no significant difference in the patient assessment scale score between the two sides at 3 months (P = 0·084)., Conclusions: We found that 1-cm suture spacing was not significantly associated with improved overall cosmetic outcome compared with 2-cm suture spacing when evaluated by blinded observers or the patients themselves. Our results support the use of either interval. What is already known about this topic? Surgeons have differing opinions on the ideal frequency of subcuticular sutures for optimizing cosmetic outcomes and minimizing suture reactions. The effect of subcuticular suture spacing on wound cosmesis has not been previously explored in the literature. What does this study add? There was no significant difference in cosmetic outcome between 1-cm suture spacing and 2-cm suture spacing when evaluated by blinded observers and patients. Dermatology surgeons can use 2-cm suture spacing for increased efficiency, without significantly different cosmetic outcomes, detected by blinded observers and patients., (© 2022 British Association of Dermatologists.)
- Published
- 2022
- Full Text
- View/download PDF
30. Focused update: Guidelines of care for the management of actinic keratosis.
- Author
-
Eisen DB, Dellavalle RP, Frazer-Green L, Schlesinger TE, Shive M, and Wu PA
- Subjects
- Acetamides, Humans, Morpholines, Pyridines, Skin pathology, Keratosis, Actinic drug therapy, Keratosis, Actinic pathology
- Abstract
Background: Actinic keratoses (AKs) are rough scaly patches that arise on chronically UV-exposed skin and can progress to keratinocyte carcinoma., Objective: In 2021, the American Academy of Dermatology published guidelines to assist in clinical decision-making for the management of AK. The purpose of this focused guideline update is to incorporate recently available evidence on the use of topical tirbanibulin to treat AK., Methods: A multidisciplinary work group conducted a systematic review to evaluate data on the use of tirbanibulin for AK and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of the evidence and formulating and grading a clinical recommendation. The graded recommendation was voted on to achieve consensus., Results: Two trials were identified, and analysis of the evidence resulted in 1 recommendation., Limitations: This analysis is based on the best available evidence at the time it was conducted. Long-term efficacy and safety data are not currently available., Conclusions: A strong recommendation for the use of topical tirbanibulin to join the currently recommended list of topical therapies for AK was made on the basis of the available evidence., Competing Interests: Conflicts of interest Work Group Members’ Disclosures: The following information represents the authors’ disclosed relationships with the industry during the focused update development process. Authors (listed alphabetically) with relevant conflicts of interest with respect to this guideline are noted with an asterisk (∗). In accordance with the American Academy of Dermatology policy, a minimum of 51% of workgroup members did not have any relevant conflicts of interest. Participation in ≥1 of the following activities constitutes a relevant conflict: service as a member of a speaker bureau or advisory board; service as a consultant for pharmaceutical companies on actinic keratosis (AK), AK drugs in development, or Food and Drug Administration approved AK drugs; or sponsored research funding or investigator-initiated studies with partial or full funding from pharmaceutical companies on AK, or AK drugs in development, or Food and Drug Administration approved AK drugs. If a potential conflict was noted, the workgroup member recused themselves from voting on the recommendations pertinent to the topic area of interest. Complete group consensus was obtained for draft recommendations. Areas where complete consensus was not achieved are shown transparently in the guideline. Dr Dellavalle serves as a principal investigator for Pfizer Inc and the US Department of Veterans Affairs, receiving grants and/or research funding; as an editorial board member for the Cochrane Collaboration, Journal of Investigative Dermatology, and the Journal of the American Academy of Dermatology, receiving other financial benefits; as an independent contractor for UpToDate Inc, receiving patent royalties and/or compensation for intellectual property rights; and as a consultant for Altus Labs and ParaPRO LLC, receiving fees and/or stock. Dr Schlesinger∗ serves as an investigator for AbbVie, Arcutis Inc, Allergan Inc, AOBiome LLC, Astellas Pharma US Inc, Biofrontera, Biorasi LLC, Boehringer Ingelheim, Brickell Biotech Inc, Bristol-Myers Squibb, Cara Therapeutics, Castle BioScience, Celgene, ChemoCentryx, Corrona Inc, Demira, Dermavant Sciences, Eli Lilly and Company, EPI Health, Galderma USA, Genentech, Janssen Pharmaceuticals Inc, Kiniksa Pharmaceuticals Ltd, Merz Aesthetics, Nimbus Therapeutics, Novartis, Pfizer Inc, Processa Pharmaceuticals, Prolacta Bioscience, Pulse Biosciences, Regeneron Pharmaceuticals Inc, Sanofi Genzyme, SiSaf Ltd, and Trevi Therapeutics, receiving grants and/or research funding; as a consultant for AbbVie, Allergan Inc, Almirall, Bristol-Meyers Squibb, CMS Aesthetics DMCE, Eli Lilly and Company, EPI Health, Foundation for Research and Education in Dermatology, Galderma USA, IntraDerm Pharmaceuticals, Kintor Pharmaceuticals Ltd, Merz Aesthetics, NextPhase Therapeutics, Novartis, Ortho Dermatologics, Plasmend, Prolacta Bioscience, Regeneron, and UCB, receiving honoraria and/or fees; as a speaker for Almirall, Demira, EPI Health, MED Learning Group, Regeneron, and Sun Pharmaceutical Industries Ltd, receiving honoraria; and as an advisory board member for Almirall, Biofrontera AG, Greenway Therapeutix (no compensation received), and Remedly Inc, receiving honoraria and/or stock. Dr Wu serves as an independent contractor for UpToDate Inc, receiving honoraria. Drs Eisen, Frazer-Green, and Shive have no conflicts of interest to declare., (Copyright © 2022 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
31. Development of international clinical practice guidelines: benefits, limitations, and alternative forms of international collaboration.
- Author
-
Alam M, Harikumar V, Kang BY, Ibrahim SA, Kibbi N, Owen JL, Maher IA, Cartee TV, Sobanko JF, Reynolds KA, Bolotin D, Waldman AH, Minkis K, Petersen B, Council ML, Nehal KS, Xu YG, Jiang SB, Somani AK, Bichakjian CK, Huang CC, Eisen DB, Ozog DM, Lee EH, Samie FH, Neuhaus IM, Bordeaux JS, Wang JV, Leitenberger JJ, Mann MW, Lawrence N, Zeitouni NC, Golda N, Behshad R, Ibrahim SF, Yu SS, Shin TM, Stebbins WG, and Worley B
- Published
- 2022
- Full Text
- View/download PDF
32. The effect of rate and temperature on patient-reported pain during local anesthesia injection: A single-blinded, randomized, controlled trial.
- Author
-
Maisel-Campbell A, Weil A, Lazaroff JM, Council ML, Eisen DB, Lawrence N, Minkis K, Chen BR, Kang BY, Ibrahim SA, Poon E, and Alam M
- Subjects
- Anesthetics, Local adverse effects, Double-Blind Method, Humans, Patient Reported Outcome Measures, Temperature, Anesthesia, Local adverse effects, Pain etiology, Pain prevention & control
- Abstract
Competing Interests: Conflicts of interest None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
33. Use of a thermoplastic splint to prevent auditory meatus stricture.
- Author
-
Mehrzad M, Danesh MJ, and Eisen DB
- Subjects
- Humans, Constriction, Pathologic prevention & control, Splints, Finger Injuries
- Published
- 2022
- Full Text
- View/download PDF
34. Principles for developing and adapting clinical practice guidelines and guidance for pandemics, wars, shortages, and other crises and emergencies: the PAGE criteria.
- Author
-
Alam M, Harikumar V, Ibrahim SA, Kang BY, Maher IA, Cartee TV, Sobanko JF, Kibbi N, Owen JL, Reynolds KA, Bolotin D, Waldman AH, Minkis K, Petersen B, Council ML, Nehal KS, Xu YG, Jiang SB, Somani AK, Bichakjian CK, Huang CC, Eisen DB, Ozog DM, Lee EH, Samie FH, Neuhaus IM, Bordeaux JS, Wang JV, Leitenberger JJ, Mann MW, Lawrence N, Zeitouni NC, Golda N, Behshad R, Ibrahim SF, Yu SS, Shin TM, Stebbins WG, and Worley B
- Subjects
- Emergencies, Humans, Practice Guidelines as Topic, COVID-19 epidemiology, Pandemics prevention & control
- Published
- 2022
- Full Text
- View/download PDF
35. Broad versus narrow clinical practice guidelines: avoiding rules for the high risk 1.
- Author
-
Harikumar V, Worley B, Ibrahim SA, Kang BY, Maher IA, Cartee TV, Sobanko JF, Kibbi N, Owen JL, Reynolds KA, Bolotin D, Waldman AH, Minkis K, Petersen B, Council ML, Nehal KS, Xu YG, Jiang SB, Somani AK, Huang CC, Eisen DB, Ozog DM, Lee EH, Samie FH, Neuhaus IM, Leitenberger JJ, Mann MW, Lawrence N, Zeitouni NC, Golda N, Behshad R, Ibrahim SF, Yu SS, Shin TM, Stebbins WG, and Alam M
- Subjects
- Humans, Evidence-Based Medicine
- Published
- 2022
- Full Text
- View/download PDF
36. Aesthetic outcome of simple cuticular suture distance from the wound edge on the closure of linear wounds on the head and neck: A randomized evaluator blinded split-wound comparative effect trial.
- Author
-
Weinkle A, Harrington A, Kang A, Armstrong AW, and Eisen DB
- Subjects
- Aged, Humans, Mohs Surgery adverse effects, Mohs Surgery methods, Sutures, Wound Healing, Cicatrix etiology, Cicatrix pathology, Cicatrix prevention & control, Suture Techniques
- Abstract
Background: Little data support the optimal distance of cuticular suture placement from the wound edge to achieve the most cosmetically appealing scar., Objective: To compare Patient and Observer Scar Assessment Scale (POSAS) scores for cutaneous sutures spaced 2 mm versus 5 mm from the wound edge in head and neck defects repaired via linear closure., Methods: Fifty patients were enrolled in this randomized, evaluator blinded, split-scar study. Surgical wounds were repaired with cuticular sutures 2 mm from the wound edge on one side and 5 mm on the other. POSAS scores and scar width were compared 3 months postoperatively., Results: The sum observer POSAS score for this study had a mean (SD) of 16.06 (6.49) on the 2-mm side and 15.82 (6.83) on the 5-mm side (P = .807). Similarly, no difference was seen between scar width with a mean (SD) of 0.100 cm (0.058 cm) on the 2-mm side and with mean (SD) 0.100 cm (0.076 cm) on the 5-mm side (P = .967)., Limitations: Linear repairs were studied on head and neck defects after extirpation of cutaneous malignancies, resulting in a homogeneous elderly white patient population., Conclusion: Cuticular sutures placed 2 or 5 mm from the wound edge did not result in different cosmetic outcomes in linear closures on the head and neck., Competing Interests: Conflicts of interest None disclosed., (Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
37. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
- Author
-
Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM Jr, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, and Alam M
- Subjects
- Aged, Humans, Imiquimod therapeutic use, Prospective Studies, Sentinel Lymph Node Biopsy, Paget Disease, Extramammary diagnosis, Paget Disease, Extramammary pathology, Paget Disease, Extramammary therapy, Skin Neoplasms diagnosis, Skin Neoplasms pathology, Skin Neoplasms therapy
- Abstract
Importance: Extramammary Paget disease (EMPD) is a frequently recurring malignant neoplasm with metastatic potential that presents in older adults on the genital, perianal, and axillary skin. Extramammary Paget disease can precede or occur along with internal malignant neoplasms., Objective: To develop recommendations for the care of adults with EMPD., Evidence Review: A systematic review of the literature on EMPD from January 1990 to September 18, 2019, was conducted using MEDLINE, Embase, Web of Science Core Collection, and Cochrane Libraries. Analysis included 483 studies. A multidisciplinary expert panel evaluation of the findings led to the development of clinical care recommendations for EMPD., Findings: The key findings were as follows: (1) Multiple skin biopsies, including those of any nodular areas, are critical for diagnosis. (2) Malignant neoplasm screening appropriate for age and anatomical site should be performed at baseline to distinguish between primary and secondary EMPD. (3) Routine use of sentinel lymph node biopsy or lymph node dissection is not recommended. (4) For intraepidermal EMPD, surgical and nonsurgical treatments may be used depending on patient and tumor characteristics, although cure rates may be superior with surgical approaches. For invasive EMPD, surgical resection with curative intent is preferred. (5) Patients with unresectable intraepidermal EMPD or patients who are medically unable to undergo surgery may receive nonsurgical treatments, including radiotherapy, imiquimod, photodynamic therapy, carbon dioxide laser therapy, or other modalities. (6) Distant metastatic disease may be treated with chemotherapy or individualized targeted approaches. (7) Close follow-up to monitor for recurrence is recommended for at least the first 5 years., Conclusions and Relevance: Clinical practice guidelines for EMPD provide guidance regarding recommended diagnostic approaches, differentiation between invasive and noninvasive disease, and use of surgical vs nonsurgical treatments. Prospective registries may further improve our understanding of the natural history of the disease in primary vs secondary EMPD, clarify features of high-risk tumors, and identify superior management approaches.
- Published
- 2022
- Full Text
- View/download PDF
38. Buried dermal set-back suture placement: Considerations for optimizing long-term outcomes.
- Author
-
Kantor J, Eisen DB, and Dzubow LM
- Subjects
- Humans, Dermatologic Surgical Procedures, Sutures
- Abstract
Competing Interests: Conflicts of interest None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
39. Guidelines of care for the management of actinic keratosis.
- Author
-
Eisen DB, Asgari MM, Bennett DD, Connolly SM, Dellavalle RP, Freeman EE, Goldenberg G, Leffell DJ, Peschin S, Sligh JE, Wu PA, Frazer-Green L, Malik S, and Schlesinger TE
- Subjects
- Diclofenac therapeutic use, Fluorouracil therapeutic use, Humans, Imiquimod therapeutic use, Keratosis, Actinic drug therapy, Photochemotherapy
- Abstract
Background: Actinic keratoses (AK) are rough scaly patches that arise on chronically ultraviolet-exposed skin and can progress to keratinocyte carcinoma., Objective: This analysis examined the literature related to the management of AK to provide evidence-based recommendations for treatment. Grading, histologic classification, natural history, risk of progression, and dermatologic surveillance of AKs are also discussed., Methods: A multidisciplinary Work Group conducted a systematic review to address 5 clinical questions on the management of AKs and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of the evidence and formulating and grading clinical recommendations. Graded recommendations were voted on to achieve consensus., Results: Analysis of the evidence resulted in 18 recommendations., Limitations: This analysis is based on the best available evidence at the time it was conducted. The pragmatic decision to limit the literature review to English language randomized trials may have excluded data published in other languages or limited identification of relevant long-term follow-up data., Conclusions: Strong recommendations are made for using ultraviolet protection, topical imiquimod, topical 5-fluorouracil, and cryosurgery. Conditional recommendations are made for the use of photodynamic therapy and diclofenac for the treatment of AK, both individually and as part of combination therapy regimens., (Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
40. Preferences for Prophylactic Oral Antibiotic Use in Dermatologic Surgery: A Multicenter Discrete Choice Experiment.
- Author
-
Aizman L, Barbieri JS, Feit EM, Lukowiak TM, Perz AM, Shin TM, Miller CJ, Golda N, Leitenberger JJ, Carr DR, Nijhawan RI, Hasan A, Eisen DB, and Etzkorn JR
- Subjects
- Administration, Oral, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Surveys and Questionnaires, Antibiotic Prophylaxis, Dermatologic Surgical Procedures, Patient Preference, Surgical Wound Infection prevention & control
- Abstract
Background: Antibiotics are often prescribed after dermatologic surgery for infection prophylaxis, but patient preferences about prophylactic antibiotics are not well understood., Objective: To understand patient preferences about taking antibiotics to prevent surgical site infection (SSI) relative to antibiotic efficacy and antibiotic-associated adverse drug reactions., Materials and Methods: Multi-center, prospective discrete choice experiment (DCE)., Results: Three hundred thirty-eight respondents completed the survey and DCE. 54.8% of respondents preferred to take an antibiotic if it reduced the SSI rate from 5% to 2.5% and if the risk of adverse drug reactions was low (1% risk gastrointestinal upset, 0.5% risk itchy skin rash, 0.01% risk emergency department visit). Even if an antibiotic could eliminate SSI risk (0% risk SSI) and had a low adverse drug reaction profile, 26.7% of respondents prefer not to take prophylactic oral antibiotics., Conclusion: Risk-benefit thresholds for taking antibiotics to prevent SSI vary widely. Clinical trials are needed to better characterize the effectiveness and risks of oral antibiotic SSI prophylaxis to guide decision-making. Future studies should also evaluate whether shared decision-making can improve the patient experience., (Copyright © 2021 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
41. Postoperative Outcomes of Local Skin Flaps Used in Oncologic Reconstructive Surgery of the Nasal Ala: A Systematic Review.
- Author
-
Nicholas MN, Liu A, Jia J, Chan AR, and Eisen DB
- Subjects
- Humans, Nose Neoplasms surgery, Plastic Surgery Procedures methods, Surgical Flaps surgery
- Abstract
Background: Despite numerous options for nasal ala reconstruction, advantages and disadvantages of each method are unclear., Objective: To summarize reported outcomes of local flaps without the use of grafts for nasal ala oncologic reconstructive surgery., Methods: A nasal ala-specific protocol was adapted from a previous head- and neck-specific PROSPERO submission (CRD42017071596). The search was conducted in MEDLINE, EMBASE, and CENTRAL on December 23, 2017 and updated on May 10, 2019. Two reviewers screened 9,313 results from head and neck literature. Study bias was evaluated with the ROBINS-I tool., Results: Subunit-based categorization of included studies identified 12 nasal ala-specific publications. Complications (flap necrosis, hematoma, wound infections, trapdoor deformities, and dehiscence), functional (nasal valve or respiratory dysfunction), and cosmetic (alar rim distortion/asymmetry/notching, secondary/revisionary procedures, and patient satisfaction) outcomes were extracted., Conclusion: Generally favorable outcomes are seen in all flaps. Careful consideration of donor sites for interpolation flaps is needed for optimal cosmetic outcomes. Transposition flaps, including laterally based bilobed and trilobed flaps, created good outcomes, although melolabial transposition flaps may produce poorer outcomes compared with melolabial island pedicle advancement flaps. Caution is needed for rotation flaps to prevent nasal valve/respiratory dysfunction due to alar crease contracture or ridge elevation. Further research is needed., (Copyright © 2021 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
42. Postoperative Outcomes of Local Skin Flaps Used in Oncologic Reconstructive Surgery of the Upper Cutaneous Lip: A Systematic Review.
- Author
-
Nicholas MN, Liu A, Chan AR, Jia J, Fuller K, and Eisen DB
- Subjects
- Esthetics, Humans, Lip pathology, Lip surgery, Lip Neoplasms pathology, Postoperative Complications etiology, Skin Transplantation methods, Surgical Flaps transplantation, Treatment Outcome, Lip Neoplasms surgery, Postoperative Complications epidemiology, Skin Transplantation adverse effects, Surgical Flaps adverse effects, Surgical Wound surgery
- Abstract
Background: Despite many options for upper lip reconstruction, each method's advantages and disadvantages are unclear., Objective: To summarize complications and functional and aesthetic outcomes of localized skin flaps for oncological reconstruction of the upper cutaneous lip (PROSPERO CRD42020157244)., Methods: The search was conducted in Ovid MEDLINE, Ovid EMBASE, and CENTRAL on December 14, 2019. Two reviewers screened 2,958 results for eligibility. Bias assessment was conducted using ROBINS-I criteria., Results: Our search identified 12 studies reporting outcomes of V-Y advancement, ergotrid, rotation, Karapandzic, alar crescent, and propeller facial artery perforator flaps. Flap complications (infection, hemorrhage/hematoma, wound dehiscence, and flap necrosis) ranged from 0% to 7.69%. Functional outcomes (salivary continence, microstomia, and paresthesia) were poorest for Karapandzic flaps. Aesthetic outcomes, when reported, stated satisfaction rates greater than 90%. V-Y advancement flaps reported the highest rates of poor scarring (0%-20%) and need for revision surgery (0%-46.7%)., Conclusion: Our results provide dermatologic surgeons an overview of upper cutaneous lip flap outcomes reported in the literature. In general, we noted high patient satisfaction rates and low complication rates. Additional research into outcomes of other commonly used flaps is needed. Standardization of reported outcomes could allow further comparison across different flaps or across studies of the same flap., (Copyright © 2021 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
43. Anogenital warts and relationship to child sexual abuse: Systematic review and meta-analysis.
- Author
-
Awasthi S, Ornelas J, Armstrong A, Johnson JA, and Eisen DB
- Subjects
- Child, Child, Preschool, Female, Humans, Male, Child Abuse, Sexual, Condylomata Acuminata diagnosis, Condylomata Acuminata epidemiology, Papilloma, Papillomavirus Infections, Warts
- Abstract
Background/objectives: In children, distinguishing anogenital warts (AGW) acquired innocently from those acquired by child sexual abuse (CSA) is challenging. High-quality studies examining this relationship are sparse. Here, we sought to evaluate the association between AGW and sexual abuse in children 12 years of age and younger with respect to wart location, age, and gender., Methods: A systematic review of Ovid MEDLINE, Embase, and Web of Science was performed for studies published on or before 2/16/2018. Studies were eligible for inclusion if they contained at least 10 patients 12 years old and younger and reported the number of patients who were sexually abused. The principal summary measures were the odds ratios (OR) of reported CSA with respect to subject age, wart location, and gender., Results: Three hundred twenty-seven studies were identified through record search. Twenty five were included in a summary synthesis (791 subjects); 10 were included in the final statistical analysis (199 subjects). In our overall review, 102 of 468 (21%) females and 36 of 204 (18%) males with AGW were abused or probably abused. Overlapping HPV types were found in abused and non-abused subjects. Perianal location and gender were not significant predictors of abuse. Both age and genital wart location (penis, vulva) did significantly predict CSA (α = .05). The odds ratio for sexual abuse of children aged 3-4 years was 7.45; 6.52 for ages 5-8 years; and 6.93 for ages 9-12 years compared to those 0-2 years of age. Genital location was associated with an OR of CSA of 5.93., Conclusions: Our systematic review supports a significant association between AGW in a child greater than 2 years of age and odds of CSA. Genital wart location significantly predicts CSA as well. HPV typing is not a reliable method to ascertain CSA. Male family members and acquaintances were the most likely perpetrators of abuse., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
44. Characteristics of patients with hidradenitis suppurativa seen at a tertiary care facility from 2009-2019: a retrospective chart review study.
- Author
-
Foolad N, Alber S, Agbai ON, Eisen DB, and Tartar D
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Analgesics, Opioid therapeutic use, Body Mass Index, California epidemiology, Child, Female, Humans, Inflammatory Bowel Diseases complications, Inflammatory Bowel Diseases epidemiology, Male, Middle Aged, Prevalence, Retrospective Studies, Sex Distribution, Smoking ethnology, Tertiary Healthcare, Young Adult, Hidradenitis Suppurativa complications, Hidradenitis Suppurativa drug therapy, Hidradenitis Suppurativa ethnology
- Published
- 2021
45. Wound eversion versus planar closure for wounds on the face or neck: A randomized split-wound comparative effectiveness trial.
- Author
-
Alexanian CC, Zhuang AR, Crispin MK, Armstrong AW, and Eisen DB
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Single-Blind Method, Treatment Outcome, Dermatologic Surgical Procedures methods, Face surgery, Neck surgery, Wound Closure Techniques
- Published
- 2020
- Full Text
- View/download PDF
46. Blunt curettage for postoperative hematomas.
- Author
-
Liu A and Eisen DB
- Subjects
- Curettage instrumentation, Hematoma etiology, Humans, Postoperative Hemorrhage etiology, Treatment Outcome, Curettage methods, Hematoma surgery, Mohs Surgery adverse effects, Postoperative Hemorrhage surgery
- Published
- 2020
- Full Text
- View/download PDF
47. Comparison of 2-Octylcyanoacrylate Versus 5-0 Fast-Absorbing Gut During Linear Wound Closures and the Effect on Wound Cosmesis.
- Author
-
Zhuang AR, Beroukhim K, Armstrong AW, Sivamani RK, and Eisen DB
- Subjects
- Aged, Esthetics, Female, Humans, Male, Middle Aged, Prospective Studies, Cicatrix prevention & control, Cyanoacrylates administration & dosage, Mohs Surgery, Sutures, Tissue Adhesives administration & dosage, Wound Healing
- Abstract
Background: Although the use of 2-octylcyanoacrylate (OCA) in cutaneous surgery offers increased efficiency, there is scant data comparing scar outcomes achieved with OCA versus 5-0 fast-absorbing gut suture (FG)., Objective: To compare scar cosmesis achieved with OCA versus FG for surgical wound closure., Materials and Methods: A total of 44 patients with postoperative defects of at least 3 cm were included. Half of each wound was randomized to receive closure with either OCA or FG. At 3 months, patients and 2 blinded observers evaluated each scar using the Patient and Observer Scar Assessment Scale (POSAS)., Results: The total observer POSAS score (mean [SD]) for the side repaired with OCA (12.3 [4.72]) and the side that received FG (11.6 [4.36]) did not differ significantly (p = .40). There was no significant difference in the total patient POSAS scores between closure with OCA (14.9 [8.67]) and FG (14.6 [8.90]) (p = .70). Based on observer POSAS scores, scar pigmentation was significantly worse on the scar half repaired with OCA (1.98 [0.91]) compared with FG (1.79 [0.80]) (p = .05)., Conclusion: With the exception of inferior scar pigmentation with OCA, there was no statistically significant difference in wound cosmesis after linear wound closure with OCA versus FG.
- Published
- 2020
- Full Text
- View/download PDF
48. 5-0 Polypropylene versus 5-0 fast absorbing plain gut for cutaneous wound closure: a randomized evaluator blind trial.
- Author
-
Eisen DB, Zhuang AR, Hasan A, Sharon VR, Bang H, and Crispin MK
- Subjects
- Absorbable Implants, Aged, Animals, Cicatrix etiology, Female, Humans, Male, Polypropylenes chemistry, Skin pathology, Wound Healing, Cicatrix prevention & control, Dermatologic Surgical Procedures, Postoperative Complications prevention & control, Suture Techniques, Sutures
- Abstract
Mixed opinions exist regarding cosmetic outcomes of 5-0 fast absorbing plain (FG) gut relative to nonabsorbable suture material, such as 5-0 polypropylene (PP). High quality randomized trials comparing these two suture materials are lacking. To determine whether the use of PP during layered repair of linear cutaneous surgery wounds improves scar cosmesis compared to wound closure with FG. A randomized, split wound, comparative effectiveness trial was undertaken. Patients were evaluated 3 months after the intervention by two blinded physicians using the validated patient observer scar assessment scale (POSAS). Patient assessments were also captured using the same instrument as well as scar width and complications. The mean sum of the six components of the POSAS was 10.26 vs 12.74 for PP and FG, respectively, significantly (p < 0.001) in favor of PP. Mean observer overall opinion similarly showed better outcomes for PP than for FG [1.88 vs 2.52, respectively (p < 0.006)]. The mean sum of the patient assessed components of the POSAS for PP and FG was 12.3 vs 14.34, respectively (p = 0.11). Patient overall opinion significantly favored PP (2.41 vs 3.14, p = 0.043). PP resulted in small but statistically significant better cosmetic outcomes than FG. Pain experienced during suture removal was minimal for most patients.
- Published
- 2020
- Full Text
- View/download PDF
49. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study.
- Author
-
Beroukhim K, Pourang A, and Eisen DB
- Subjects
- Aged, Cohort Studies, Female, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Risk Assessment, Melanoma epidemiology, Neoplasms, Second Primary epidemiology, Skin Neoplasms epidemiology
- Abstract
Background: While cutaneous melanomas (CM) account for greater than 90% of all melanomas, noncutaneous melanomas (NCM) are more aggressive and associated with worse outcomes. The shared progenitor cell type among CM and NCM suggests that patients with a history of CM may be at higher risk for subsequent NCM., Objective: To determine whether patients with a history of CM demonstrate an increased risk of second primary cutaneous, ocular, oral, or vaginal/exocervical melanoma compared with the general population., Methods: This was a population-based retrospective cohort study using the Surveillance, Epidemiology, and End Results database. We calculated standardized incidence ratios (SIRs) and excess absolute risks of second primary cutaneous, ocular, oral, and vaginal/exocervical melanoma in patients with a history of CM., Results: Patients with prior CM (n = 169,841) were more likely than the general population to develop a second primary CM (SIR, 8.17; 95% confidence interval [CI], 8.01-8.33), ocular melanoma (SIR, 1.99; 95% CI, 1.54-2.53), oral melanoma (SIR, 6.87; 95% CI, 2.23-16.04), and vaginal/exocervical melanoma (SIR, 10.17; 95% CI, 4.65-19.30)., Limitations: This study is limited by possible under-reporting of CM in cancer registries., Conclusion: In caring for patients with a history of CM, physicians should be vigilant not only about risk of recurrence but also about second primary CM and NCM., (Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
50. Dermal suture only versus layered closure: A randomized, split wound comparative effectiveness trial.
- Author
-
Joo JS, Zhuang AR, Tchanque-Fossuo C, Tartar D, Armstrong AW, King TH, Sivamani RK, and Eisen DB
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Prospective Studies, Single-Blind Method, Treatment Outcome, Cicatrix prevention & control, Dermatologic Surgical Procedures methods, Postoperative Complications prevention & control, Suture Techniques
- Abstract
Background: Layered closure of cutaneous wounds is a commonly used surgical practice. However, there are studies that suggest the additional layer of epidermal sutures might not be necessary., Objective: To compare scar outcomes between the single-layer deep-dermal suture technique and the conventional layered suture technique for primary closure of cutaneous wounds., Methods: A total of 49 patients were enrolled in a prospective, randomized, evaluator-blinded, split scar study to compare the conventional bilayered closure technique with the single-layer deep-dermal suturing technique for primary closure of wounds. The primary outcome measure was mean sum Patient and Observer Scar Assessment Scale (POSAS) score at 3 and 12 months., Results: At the 3-month follow-up, there was a statistically significant difference in the mean total POSAS scores for both the blinded observer and patients, indicating a preference for the side with the standard layered closure. However, at the 12-month follow-up, this difference was lost, with the exception of scar color, which was significantly more noticeable on the wound side closed with only dermal sutures., Limitation: Single-center study., Conclusion: Three months after surgery, the layered closure technique resulted in a slightly better scar outcome than the single-layered closure containing only dermal sutures. At 12-months' follow-up, this difference diminished, with scars for both sides appearing similar., (Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.